Trials / Active Not Recruiting
Active Not RecruitingNCT04164966
Development of Novel Biomarkers for the Early Diagnosis of Type 1 Diabetes
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 28 (actual)
- Sponsor
- AdventHealth Translational Research Institute · Academic / Other
- Sex
- All
- Age
- 12 Years – 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to measure the levels of certain substances (biomarkers) in the body that may indicate the triggers of Type 1 Diabetes, to find a better way to diagnose the disease, as well as to follow its progression.
Conditions
Timeline
- Start date
- 2019-11-27
- Primary completion
- 2024-07-23
- Completion
- 2026-12-01
- First posted
- 2019-11-15
- Last updated
- 2026-03-30
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04164966. Inclusion in this directory is not an endorsement.